“…It is difficult to arrive at an actual incidence of RCM-associated renal dysfunction, largely due to varying definitions among the various studies. This incidence is extended between 0% in a random population and 92% in a high-risk population, that is, those with diabetes or heart failure with preexising renal insufficiency (Alexander et al, 1978;Barrett et al, 1992;Berg et al, 1992;Berns, 1989;Byrd and Sherman, 1979;Carvallo et al, 1975;Cochran et al, 1983;Cramer et al, 1985;D'Elia et al, 1982;Davidson et al, 1989;Diaz-Buxo et al, 1975;Gale et al, 1984;Gomes et al, 1989;Harkonen and Kjellstrand, 1981;Katholi et al, 1993;Khoury et al, 1983;Kinnison et al, 1989;Krumlovsky et al, 1978;Mason et al, 1985;Parfrey et al, 1989;Pathria et al, 1987;Pelz et al, 1984;Pendergrass et al, 1942;Pendergrass et al, 1955;Pillay et al, 1970;Quader et al, 1998;Roy et al, 1985;Rudnick et al, 1995;Schwab et al, 1989;Shafi et al, 1978;Shieh et al, 1982;Shusterman et al, 1987;Sunnegardh et al, 1990;Taliercio et al, 1986;Teruel et al, 1981;Waybill and Waybill, 2001;Weinrauch et al, 1977).…”